fda-inspection-records

Drugs: FDA inspections and Form 483 observations

18,949 firms with at least one Drugs inspection. Most serious classification on file: 7,396 NAI, 9,164 VAI, 2,389 OAI.

The 25 observations cited most often (Drugs program)

RegulationObservationTimes cited
21 CFR 211.22(d)Procedures not in writing, fully followed2,399
21 CFR 211.192Investigations of discrepancies, failures1,535
21 CFR 211.160(b)Scientifically sound laboratory controls1,444
21 CFR 211.100(a)Absence of Written Procedures1,419
21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance940
21 CFR 211.67(b)Written procedures not established/followed874
21 CFR 211.165(a)Testing and release for distribution849
21 CFR 211.110(a)Control procedures to monitor and validate performance751
21 CFR 211.166(a)Lack of written stability program704
21 CFR 211.63Equipment Design, Size and Location697
21 CFR 211.68(a)Calibration/Inspection/Checking not done693
21 CFR 211.113(b)Procedures for sterile drug products678
21 CFR 211.100(b)SOPs not followed / documented632
21 CFR 211.25(a)Training--operations, GMPs, written procedures628
21 CFR 211.188Prepared for each batch, include complete information583
21 CFR 211.68(b)Computer control of master formula records575
21 CFR 211.22(a)Lack of quality control unit473
21 CFR 211.198(a)Complaint Handling Procedure451
21 CFR 211.42(c)(10)(iv)Environmental Monitoring System451
21 CFR 211.84(d)(2)Reports of Analysis (Components)432
21 CFR 211.180(e)(2)Items to cover on annual reviews414
21 CFR 211.165(e)Test methods400
21 CFR 211.25(a)Training , Education , Experience overall398
21 CFR 211.192Written record of investigation incomplete384
21 CFR 211.113(b)Validation lacking for sterile drug products381

Frequencies of posted Form 483 citations, all fiscal years. They describe what investigators write most often, not any firm.

By state